Although all enrolled patients had NAFLD, their liver function test results were almost within normal limits (37.6 ± 39.4 IU/L, 27.7 ± 15.4 IU/L, and 32.3 ± 21.5 IU/L for γ-GT, AST, and ALT, respectively). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.